Pharmaceutical Receivables, the Source of the Pharmaceutical Units Solvency

Doina Margaritti
Additional contact information
Doina Margaritti: Ovidius University of Constanta, Romania

Risk in Contemporary Economy, 2016, 297-305

Abstract: The objective of this work is to analyze the current assets recorded by the pharmaceutical units, namely the role of the pharmaceutical receivables to improve the financial performances carried out by the pharmaceutical entities. The study was carried out through the analysis of the financial statements drawn up by a community pharmaceutical entity from Bucharest. In order to achieve the proposed objective, we analyzed the current assets in their structure, namely the pharmaceutical receivables which are to be recovered by the Bucharest Health Insurance House and the Insurance House OPSNAJ, resulting from the issuance of the compensated drugs prescriptions. Thus, it was determined the total receivables, but also differentiated release programs, how they are created, the term of settlement and the manner in which they have influenced the level of financial performance indicators.

Date: 2016
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.rce.feaa.ugal.ro/images/stories/RCE2016/DoinaMargaritti.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ddj:fserec:y:2016:p:297-305

Access Statistics for this article

More articles in Risk in Contemporary Economy from "Dunarea de Jos" University of Galati, Faculty of Economics and Business Administration Contact information at EDIRC.
Bibliographic data for series maintained by Gianina Mihai ().